1993
DOI: 10.1093/ajcn/57.5.650
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients

Abstract: Ten control (healthy) subjects and 15 non-insulin-dependent diabetics underwent an oral glucose-tolerance test and a euglycemic hyperinsulinemic glucose clamp before and after vitamin E supplementation (900 mg/d for 4 mo). In control subjects (placebo-treated vs vitamin E-supplemented subjects, respectively) vitamin E reduced the area under the curve for glucose (344 +/- 21 vs 287 +/- 13 mmol.L-1 x min-1; P < 0.05) and increased total body glucose disposal (39.0 +/- 0.3 vs 47.6 +/- 0.4 mumol.kg lean body mass-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
122
2
6

Year Published

1994
1994
2008
2008

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 293 publications
(135 citation statements)
references
References 24 publications
5
122
2
6
Order By: Relevance
“…The results obtained from this study have revealed that there is a relationship between vitamin E and glucose metabolism, as there was an increase in insulin sensitivity in diabetic rats treated with vitamin E. This was in agreement with the results of previous studies that antioxidant like vitamin E improves insulin sensitivity in diabetics (26). The reduction in the glucose levels of the diabetic control animals may also be due to partial recovery.…”
Section: Discussionsupporting
confidence: 92%
“…The results obtained from this study have revealed that there is a relationship between vitamin E and glucose metabolism, as there was an increase in insulin sensitivity in diabetic rats treated with vitamin E. This was in agreement with the results of previous studies that antioxidant like vitamin E improves insulin sensitivity in diabetics (26). The reduction in the glucose levels of the diabetic control animals may also be due to partial recovery.…”
Section: Discussionsupporting
confidence: 92%
“…It has not usually been thought that free radicals affect the ef®cacy of insulin on peripheral cells. Interestingly, however, pharmacological doses of tocopherol, one of the most important exogenous antioxidants, have recently been reported to enhance the action of insulin (Paolisso et al, 1993a). Although not much is known about the contribution made by free radicals to the pathogenesis of NIDDM, more is known about their role in the pathogenesis of diabetic complications.…”
Section: Discussionmentioning
confidence: 99%
“…Tocopherol in pharmacological doses reduces indicators of oxidative stress (Ka Èhler et al, 1993) and protein glycosylation (Ceriello et al, 1991) in diabetic patients, and thus could therefore be bene®cial in preventing diabetic complications (Baynes, 1991). Pharmacological doses of vitamin E have also been shown to reduce insulin resistance (Paolisso et al, 1993a(Paolisso et al, , 1994 and improve metabolic control in NIDDM patients (Paolisso et al, 1993b). In the ®rst prospective population study involving Serum antioxidants and risk of non-IDDM A Reunanen et al middle-aged men, high serum concentrations of a-tocopherol were shown to protect against development of NIDDM (Salonen et al, 1995).…”
Section: Discussionmentioning
confidence: 99%
“…Recent findings suggest that metabolic processes following a meal may increase oxidative stress (Ceriello et al, 1999;Rao & Agarwal, 1999). A direct link has been found between postprandial glycemia and the induction of oxidative stress (Ceriello et al, 1998a(Ceriello et al, ,1999) that can be reversed by antioxidants (Paolisso et al, 1993(Paolisso et al, ,1994Sharma et al, 2000). In this respect, possible mechanisms of action of low-GI diets include reduction of: (i) glucose toxicity, ie the effect of high glucose levels in depressing pancreatic function through free radical damage of pancreatic b cells; and (ii) glycosylation of proteins and key enzymes responsible for metabolic processes (advanced glycosylation end products -AGE, Paolisso et al, 1992;Ceriello, 2000).…”
Section: Glycemic Index In Chronic Diseasementioning
confidence: 99%